NeuroSense Therapeutics L... (NRSNW)

0.15

-0.05 (-25.00%)

At close: Mar 03, 2025, 11:53 AM

0.21

40.24%

Pre-market: Mar 03, 2025, 11:54 AM EST

NeuroSense Therapeutics Ltd. Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-11.28M	-12.34M	-4.04M	-2.83M	-1.22M
Depreciation & Amortization	97K	89K	3K	3K	n/a
Stock-Based Compensation	1.54M	5.11M	4.16M	2.06M	611K
Other Working Capital	928K	291K	289K	37K	6K
Other Non-Cash Items	1.3M	-1.19M	791K	-2K	591K
Deferred Income Tax	-2.01M	n/a	-2.72M	2K	n/a
Change in Working Capital	1.91M	750K	273K	69K	29K
Operating Cash Flow	-8.45M	-7.59M	-1.54M	-695K	-582K
Capital Expenditures	-29K	-70K	-17K	-9K	-7K
Acquisitions	3K	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-3.5M	n/a	n/a	-19K
Sales Maturities Of Investments	3.5M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-6K	29K	n/a	n/a	-19K
Investing Cash Flow	3.47M	-3.54M	-17K	-9K	-26K
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-75K	3.69M	2.04M	n/a	-3K
Financial Cash Flow	3.9M	3.69M	11.9M	508K	1.42M
Net Cash Flow	-903K	-7.52M	10.36M	-196K	809K
Free Cash Flow	-8.48M	-7.66M	-1.56M	-704K	-589K